Upal Basu Roy: CliniTrial 2024 by the University of Chicago
Upal Basu Roy, Executive Director of Research at LUNGevity Foundation, shared a post on LinkedIn by Rajat Thawani, Assistant Professor of Thoracic Oncology at the University of Chicago, adding:
“This forum is so close to both my heart and my mind! A huge shout-out of gratitude to Dr. Rajat Thawani, Dr. Suresh S. Ramalingam, MD, and the University of Chicago for pioneering this vital platform aimed at strengthening capacity to conduct clinical trials in LMICs like India.
Since Day 1, LUNGevity Foundation has been a champion of clinical research, investing in groundbreaking studies to transform lung cancer care. As cancer rates continue to rise in LMICs, the need for robust clinical research has never been more – for a future where access to innovative treatments is a reality for all people living with cancer, everywhere.”
Quoting Rajat Thawani’s post:
“One week to go!
International Faculty – Suresh S. Ramalingam, MD, Upal Basu Roy, PhD, MPH, Geetika Srivastava, MD.
Eminent Faculty and Resource Persons – Upreet Dhaliwal, Khan Amir Maroof, MD, Satendra Singh, MD, Arun Sharma, Navjeevan Singh, and Tarunima Malik Grover.
Organized by bcpbf-The Cancer Foundation with Sameer Kaul, University College of Medical Sciences, and UChicago Center in Delhi University of Chicago.”
More posts featuring Upal Basu Roy and Rajat Thawani.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023